| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 2 | |
| #2 | Canada | 2 | |
| #3 | EPO (European Patent Office) | 2 | |
| #4 | Republic of Korea | 2 | |
| #5 | United States | 2 | |
| #6 | WIPO (World Intellectual Property Organization) | 2 | |
| #7 | Mexico | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Measurement | |
| #3 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Tang Min | 12 |
| #2 | Shan Joseph S | 10 |
| #3 | Chang Connie | 6 |
| #4 | King Steven W | 5 |
| #5 | Kallinteris Nikoletta L | 5 |
| #6 | Brown Michael A | 5 |
| #7 | Dorr Andrew F | 4 |
| #8 | Shan Joseph | 2 |
| #9 | Kallinteris Nikoletta | 1 |
| #10 | Min Tang | 1 |
| Publication | Filing date | Title |
|---|---|---|
| AU2018249493A1 | Methods for treating cancer using PS-targeting antibodies with immuno-oncology agents | |
| US2021032340A1 | Methods for treating cancer with bavituximab based on levels of beta2-glycoprotein 1, and assays therefor | |
| EP3519827A1 | Methods for treating cancer with bavituximab based on levels of 2-glycoprotein 1, and assays therefor |